JP Morgan Chase’s Prothena Corp PRTA Stock Holding History
Bought
Maintained
Sold
Other funds holding PRTA
RCMNY
ACM
VPM
PAI
JP Morgan Chase's PRTA Position: Q1 2026 in Review
JP Morgan Chase reduced its Prothena Corp (PRTA) stake by 85% in Q1 2026, selling an estimated $1.32M and leaving 25,967 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #5394.
JP Morgan Chase first reported a position in PRTA in Q3 2013 and has held it in 48 quarters since. The position peaked at $28.3M in Q2 2023. 185 funds tracked by Wall St. Rank hold PRTA as of Q1 2026.
- JP Morgan Chase held 25,967 shares of Prothena Corp worth $240K as of Q1 2026.
- JP Morgan Chase sold 143,988 Prothena Corp shares in Q1 2026, an estimated $1.32M.
- Prothena Corp made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5394 holding.
- JP Morgan Chase first reported a position in Prothena Corp in Q3 2013 and has held it in 48 quarters since.
- JP Morgan Chase's Prothena Corp position peaked at $28.3M in Q2 2023.
- 185 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.